期刊文献+

e抗原阴性慢性乙型肝炎临床病理相关性分析 被引量:3

Clinical pathology character analysis of HBeAg-negative chronic hepatitis B
下载PDF
导出
摘要 目的了解HBeAg阴性慢性乙型肝炎临床和病理表现的相互关系。方法对154例HBeAg阴性慢性乙型肝炎患者进行血生化、病毒标志物及病毒定量检测,与肝组织病理进行相关性分析。结果病理诊断中、重度患者数量多于临床分度数量(80例对37例),白蛋白/球蛋白和凝血酶原活动度(PTA)对重度肝炎诊断有一定的临床价值.HBV DNA水平和抗-HBe是否阳性与肝脏损害程度无关,血清透明质酸水平与肝纤维化程度相关(X^2=6.937 6,P=0.039)。结论HBeAg阴性慢性乙型肝炎患者应尽可能行肝脏病理检查以明确诊断,并指导治疗。 Objective To analyse the clinical and pathologic characters of HBeAg-negative chronic hepatitis B patients. Methods 154 HBeAg-negative chronic hepatitis B patients were selected, liver function test, virus marker and virus loading were observed, correlation analysis was performed with pathological grading. Results The patient's number diagnosed by pathology from moderate to severe hepatitis is higher than that diagnosed by clinical manifestation (80 vs 37). It is valuable clinically to diagnose severe hepatitis with albumin/globulin and prothrombin activity(PTA). Serum HBV DNA level and anti-HBe status cann't reflect grading of liver inflammation, but hyaluronic acid level is correlated with liver fibrosis (χ^2 = 6. 937 6,P = 0. 039). Conclusion Liver biopsy and pathologic examination should be carried out in HBeAg-negative chronic hepatitis B patients.
出处 《肝脏》 2008年第1期11-13,共3页 Chinese Hepatology
关键词 肝炎E抗原 乙型 慢性乙型肝炎 透明质酸 病理学 HBeAg Chronic hepatitis B Hyaluronic acid Pathology
  • 相关文献

参考文献6

  • 1Montazeri G,Estakhri A,Mohamadnejad M,et al.Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.BMC Gastroenterol,2005, 5:32.
  • 2Rezende RE,Fonseca BA,Ramalho LN,et al.The precore mutation is associated with severity of liver damage in Brazilian patients with chronic hepatitis B.J Clin Virol,2005,32:53-59.
  • 3Lin CL,Liao LY,Wang CS,et al.Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen negative chronic hepatitis B.Liver Int,2005,25:564-570.
  • 4张玲,朱江华,马韵,张华荣.乙型肝炎病毒核酸定量检测与临床的关系[J].中华肝脏病杂志,2002,10(1):49-51. 被引量:63
  • 5Di Marco V,Marzano A,Lampertico P,et al.Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine.Hepatology,2004,40:883-891.
  • 6Papatheodoridis GV,Dimou E,Dimakopoulos K,et al.Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.Hepatology, 2005,42:121-129.

二级参考文献4

共引文献62

同被引文献20

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部